In cell-based and animal studies, GHRH-receptor agonism (tesamorelin) and GHS-R1a agonism (ipamorelin) have been reported to engage different intracellular signaling cascades that both terminate in growth-hormone secretion, an arrangement investigators have explored for potentially amplified, rather than simply additive, secretory responses
IOW, might be a much safer alternative Obesity is one of those things that many (most?) people dont (or dont want to) understand
Here is what the research and real-world experience show
Importantly, these skin-related side effects were generally mild to moderate in severity and did not result in the discontinuation of retatrutide or placebo
Cells 10 (10), 2550
VS, DO, and CS acknowledge support from the National Research Council of Canada through its Quantum Sensors Challenge Program, from the Natural Sciences and Engineering Research Council through its Discovery Grant Program and the Alliance quantum consortia grant Quantum Enhanced Sensing and Imaging
